Balance Sheet Account Details

6 Months Ended

Jun. 30, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Balance Sheet Account Details

Balance Sheet Account Details

Accounts Receivable

	June 30, 2022		December 31, 2021
Accounts receivable, net:
Accounts receivable, trade	$	5,314,000	$	5,624,000
Less allowance for doubtful accounts	(463,000)		(690,000)
	$	4,851,000	$	4,934,000

Inventory

The components of inventories are as follows:

	June 30, 2022		December 31, 2021
Inventory:
Raw materials	$	837,000	$	745,000
Finished goods	19,754,000		11,642,000
	$	20,591,000	$	12,387,000

Intangible Assets

Intangible assets that are subject to amortization consisted of the following for the periods presented:

	June 30, 2022						December 31, 2021
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Trade name	$	1,630,000	$	(372,000)	$	1,258,000	$	1,630,000	$	(210,000)	$	1,420,000
Customer relationships	3,950,000		(773,000)		3,177,000		3,950,000		(378,000)		3,572,000
Developed technology	22,800,000		(3,230,000)		19,570,000		22,800,000		(950,000)		21,850,000
Intangibles, net	$	28,380,000	$	(4,375,000)	$	24,005,000	$	28,380,000	$	(1,538,000)	$	26,842,000

Accrued Expenses

Accrued expenses consist of the following:

	June 30, 2022		December 31, 2021
Compensation expenses	$	4,861,000	$	4,529,000
Goods received not invoiced	1,238,000		1,073,000
Customer deposits	73,000		826,000
Taxes payable	722,000		677,000
Insurance	—		1,011,000
Professional fees and royalties	368,000		288,000
Warranty liabilities	175,000		175,000
Accrued clinical study fees	169,000		1,000
Other	154,000		1,114,000
Total	$	7,760,000	$	9,694,000